Clearday’s 2022 Year to Date Update
21 nov. 2022 16h46 HE
|
Clearday, Inc.
San Antonio, Texas, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Clearday, Inc. (OTCQX:CLRD) (the Company or Clearday) is pleased to report its continued development of care for older Americans as it has moved...
Final Results from Phase 2 INSTANT Trial of InRhythm™ for the Treatment of Newly Diagnosed and Recurrent Paroxysmal Atrial Fibrillation Presented at 2022 American Heart Association Scientific Sessions
07 nov. 2022 07h00 HE
|
InCarda Therapeutics, Inc.
Data Demonstrate Orally Inhaled Flecainide May Provide a Safe, Effective, and Convenient First-Line Treatment Option for Cardioversion of Recent-Onset Newly Diagnosed and Paroxysmal Atrial...
HeartFlow Announces Late Breakers Presentation at the 2022 American Heart Association (AHA) Scientific Sessions
03 oct. 2022 08h00 HE
|
HeartFlow Holding, Inc.
MOUNTAIN VIEW, Calif., Oct. 03, 2022 (GLOBE NEWSWIRE) -- HeartFlow, Inc., the leader in revolutionizing precision heart care, announced that the results of the Prospective Randomized Trial of the...
Esperion Presents Important New Science Highlighting Potential Benefits of NEXLETOL® (bempedoic acid) Tablets at American Heart Association Scientific Sessions 2021
12 nov. 2021 07h00 HE
|
Esperion Therapeutics, Inc.
- Analysis of pooled Phase 3 data showed that NEXLETOL [bempedoic acid (BA)] alone lowered LDL-C levels comparable to that of a moderate- or high-intensity statin (≥ 30%) in nearly 1 out of 3 of...
Imara to Report Data Demonstrating the Potential of Tovinontrine (IMR-687) for the Treatment of Heart Failure with Preserved Ejection Fraction (HFpEF)
08 nov. 2021 07h00 HE
|
Imara, Inc.
Preclinical data from three different mouse models of HFpEF to be presented at American Heart Association (AHA) Scientific Sessions HFpEF development to be led by cardiologist Toni Bransford, M.D.,...
Esperion to Present Key Science at the American Heart Association Scientific Sessions 2021
01 nov. 2021 16h01 HE
|
Esperion Therapeutics, Inc.
ANN ARBOR, Mich., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced the presentation of three abstracts at the American Heart Association (AHA) Scientific Sessions 2021...
InCarda Therapeutics Presents Positive New Data from Phase 2 Study of InRhythm™ in Patients with Paroxysmal Atrial Fibrillation at American Heart Association Scientific Sessions 2020
13 nov. 2020 10h00 HE
|
InCarda Therapeutics, Inc.
Data Demonstrate Achievement of Rapid Conversions from Atrial Fibrillation to Normal Sinus Rhythm Study Findings Provide Proof of Concept for First-of-its-Kind Inhaled Antiarrhythmic for Treatment of...
USI Recognized for Workplace Health Achievement by the American Heart Association for Second Consecutive Year
23 oct. 2019 08h50 HE
|
USI Insurance Services
VALHALLA, N.Y., Oct. 23, 2019 (GLOBE NEWSWIRE) -- The results of the American Heart Association’s 2019 Workplace Health Achievement Index were announced on October 21, 2019, and USI Insurance...
DCP Midstream Presents $930,000 to the American Heart Association at Colorado Avalanche Game
02 avr. 2019 18h59 HE
|
DCP Midstream LP
DENVER, April 02, 2019 (GLOBE NEWSWIRE) -- For every save made by the Colorado Avalanche goalies throughout the 2018-19 regular season, DCP Midstream committed to donating $250 to the American Heart...
VITAS Healthcare Boosts Heart Care and Education in Lake and Sumter Counties with $50,000 Donation
12 nov. 2018 10h58 HE
|
VITAS Healthcare
Eustis, Fla., Nov. 12, 2018 (GLOBE NEWSWIRE) -- In its first year of operation in Lake and Sumter counties, VITAS Healthcare, the nation’s leading provider of end-of-life care, is partnering with...